From the *Department of Pediatrics, University of Cincinnati College of Medicine; Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; †Harvard Medical School; Division of Emergency Medicine, Boston Children's Hospital, Boston, MA; ‡Department of Pediatrics, Washington University in St. Louis; Division of Pediatric Emergency Medicine, St. Louis Children's Hospital, St. Louis, MO; §Emergency Medicine and Pediatrics, San Diego School of Medicine, University of California; Division of Emergency Medicine, Rady Children's Hospital, San Diego, CA; Department of Emergency Medicine, UC San Diego Health System, San Diego, CA; and ∥University of Pittsburgh School of Medicine; Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA; on behalf of the PEM Fellowship Directors' Writing Group.
Published: July 2016
AI Article Synopsis
Article Abstract
This article is the third in a 7-part series that aims to comprehensively describe the current state and future directions of pediatric emergency medicine fellowship training from the essential requirements to considerations for successfully administering and managing a program to the careers that may be anticipated upon program completion. This article focuses on the clinical aspects of fellowship training including the impact of the clinical environment, modalities for teaching and evaluation, and threats and opportunities in clinical education.
This review focuses on chronic pediatric skin conditions-vitiligo, psoriasis, alopecia, and eczema-and their profound psychosocial impact on children and adolescents. Currently, a comprehensive comparative analysis across these conditions is absent, and comparisons between diverse psychosocial measures are lacking. This review aims to bridge that gap through a systematic review analyzing studies from PubMed and Embase up to April 2023 according to PRISMA.
Department of Emergency Medicine, Division of Medical Toxicology, University of Pittsburgh Medical Center, 3600 Forbes Avenue, Iroquois Building, 4th floor, Suite 400, Pittsburgh, PA, 15213, USA.
Paediatric critical care units are designed for children at a vulnerable stage of development, yet the evidence base for practice and policy in paediatric critical care remains scarce. In this Health Policy, we present a roadmap providing strategic guidance for international paediatric critical care trials. We convened a multidisciplinary group of 32 paediatric critical care experts from six continents representing paediatric critical care research networks and groups.
Objectives: Intestinal ultrasound (IU) has emerged as an alternative to detect bowel wall inflammation. The aim of this study was to compare IU findings to clinical disease, fecal calprotectin (FC), and endoscopic findings in newly diagnosed pediatric inflammatory bowel disease (IBD) patients.
Methods: This study was a 1-year, single-center, prospective study.
Berberine, an isoquinoline alkaloid derived from various medicinal plants, emerges as a potential therapeutic agent against diverse human diseases. It has particularly shown notable anticancer efficacy against breast, colorectal, lung, prostate, and liver cancer. Berberine results in inhibition of cancer cell proliferation, induction of apoptosis, and suppressing angiogenesis, positioning it as a versatile, multitargeted therapeutic tool against cancer.
